The Nifty 50 index began 2025 on a positive note, gaining 1.88% on January 2 to close at 24,188.65 points, up from 23,742.90 previously. Over the past year, the index delivered an impressive 11.64% return, with a 52-week range between 21,137.20 and 26,277.35 points, highlighting its robust growth trajectory.
Influence of HMPV on Nifty 50
As of now, the Nifty 50 index is trading at around 23,607.30, down 1.66% (397.45 points) amid a broader market downturn, with the Sensex also seeing sharp losses exceeding 1,200 points during the session. The decline is linked to concerns over Human Metapneumovirus (HMPV), following reports of cases in Bengaluru, sparking fears of public health and economic disruptions. Investor sentiment has turned cautious, driving profit-booking and selling pressure.
What is happening in the world?
The recent outbreak of human metapneumovirus (HMPV) in China has sparked global health concerns, reminiscent of the COVID-19 pandemic. HMPV, a respiratory virus identified in 2001, causes symptoms similar to the common cold but can lead to severe complications in vulnerable groups such as infants, the elderly, and immunocompromised individuals.
The outbreak, primarily affecting children under 14, has seen a surge in cases across northern China during the winter season, coinciding with an increase in respiratory infections like influenza A and Mycoplasma pneumoniae. Reports of overcrowded hospitals and social media images of the strain on healthcare facilities have heightened public concern.
Chinese authorities have responded with emergency measures while emphasising that the spike aligns with typical seasonal trends and is less severe than previous health crises. The World Health Organisation (WHO) has not declared a global emergency but is monitoring the situation closely.
Meanwhile, neighbouring regions, including Hong Kong and India, have reported rising cases, with India confirming its first case in Bengaluru. While international attention remains high, health officials maintain that the current HMPV surge is a seasonal phenomenon rather than a severe outbreak, with continued assessments to address any potential risks.
First case in bangalore
Two infants in Bengaluru have tested positive for Human Metapneumovirus (HMPV), marking India’s first confirmed cases. A 3-month-old female infant, diagnosed with bronchopneumonia, has been discharged, while an 8-month-old male infant, who tested positive on January 3, 2025, is recovering.
Both are local residents with no international travel history, indicating non-imported infections. Karnataka health officials are conducting further tests amid a surge in HMPV cases in China. Health Minister Dinesh Gundu Rao reassured the public that HMPV is not new and typically causes self-limiting respiratory infections, urging calm and vigilance.
Government’s response
The Indian government has responded proactively to concerns about human metapneumovirus (HMPV), focusing on monitoring and preparedness amid reports of outbreaks in China. While Karnataka issued an advisory confirming no cases as of January 5, 2025, two HMPV cases were confirmed in Bengaluru infants by January 6.
Both had bronchopneumonia, recovered, and had no international travel history. The Union Health Ministry reassured the public of no unusual surge in respiratory illnesses and emphasised India’s preparedness, urging hygiene and strict hospital monitoring.
Also read….
Is vaccine available?
Human metapneumovirus (HMPV) currently has no approved vaccine, despite over two decades of research. Preventive strategies, such as handwashing and mask-wearing, are emphasised in the absence of a vaccine. Research efforts include exploring multi-epitope mRNA and subunit vaccines, but none have advanced to human trials. For severe cases, supportive care like oxygen therapy and intravenous fluids remains the primary treatment. While vaccine development continues, no options are available for public use yet.
To protect one self
To protect yourself from Human Metapneumovirus (HMPV), practice good hygiene by washing hands frequently for at least 20 seconds or using alcohol-based hand sanitiser, covering coughs and sneezes with a tissue or elbow, and avoiding touching your face with unwashed hands. Practice social distancing by avoiding close contact with individuals showing respiratory symptoms, staying at a safe distance in crowded places, and isolating yourself if you have symptoms like fever or cough.
Disinfect commonly touched surfaces, wear masks in crowded or enclosed spaces, stay informed on health advisories, and seek medical attention if symptoms worsen, especially with difficulty breathing. These measures can significantly reduce the risk of contracting HMPV and other respiratory illnesses.
Where is Nifty 50 headed?
The recent detection of Human Metapneumovirus (HMPV) cases in India, particularly in Bengaluru, has triggered market volatility, causing the Nifty 50 index to drop nearly 1.66%. This sell-off saw the BSE Sensex fall by over 1,100 points, with sectors like metals, PSU banks, real estate, and oil and gas experiencing significant declines.
Major companies, including HDFC Bank and Reliance Industries, also saw stock value drops. If HMPV escalates into a wider epidemic, concerns about economic disruptions and public health measures could further depress market sentiment, potentially pushing the Nifty towards lower support levels of 23,000 or beyond. The India VIX has surged by 13%, reflecting increased investor fear. However, if the outbreak remains contained, government assurances and monitoring may help stabilise the market.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
